‘Clinically important’ cardiovascular benefits with antidiabetic agents
Research focusing on the newer oral antidiabetic agents reveals “clinically important” reductions in cardiovascular outcomes and mortality, relative to no treatment, among patients treated in primary care.
Source: MedWire News - Category: Consumer Health News Tags: Diabetes Source Type: news